No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
TRIB Trinity Biotech
- 1.8054
- -0.0746-3.97%
Close Apr 19 16:00 ET
13.80MMarket Cap-5768P/E (TTM)
1.8400High1.7994Low5.75KVolume1.8400Open1.8800Pre Close10.39KTurnover0.23%Turnover RatioLossP/E (Static)7.64MShares5.501552wk High-0.79P/B4.46MFloat Cap1.790052wk Low--Dividend TTM2.47MShs Float143.4487Historical High--Div YieldTTM2.16%Amplitude1.7900Historical Low1.8070Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading
European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending lower Wednesday morning, falling 0.3% to 1,330.47 on the S&P Europe Select ADR Index. From continental Europe, the gain
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
European equities traded in the US as American depositary receipts were lower Friday morning, falling 0.66% to 1,356.48 on the S&P Europe Select ADR Index. The index is poised to close the week down n
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
European equities traded in the US as American depositary receipts were weaker Thursday morning, falling 0.91% to 1,353.49 on the S&P Europe Select ADR Index.
Trinity Biotech PLC (TRIB) Q4 2023 Earnings Call Transcript Highlights: A Glimpse Into ...
Trinity Biotech Accelerates Transformation and Growth
Comments
Hmm? Would like to see! Hehehe
$Trinity Biotech(TRIB.US$ Trinity Biotech Says It Is Targeting Approximately $20M Of Annualized Run-rate EBITDA On Annualized Run-rate Revenues Of Approximately $75M By Q2, 2025
Moomoo 24/7· 2 mins ago
The company said this outlook is predicated solely on growth from the existing businesses including haemoglobin testing and HIV, and planned improvements to operating margins, with no contribution from the recently acquired biosensor business.
Moomoo 24/7· 2 mins ago
The company said this outlook is predicated solely on growth from the existing businesses including haemoglobin testing and HIV, and planned improvements to operating margins, with no contribution from the recently acquired biosensor business.
$Trinity Biotech(TRIB.US$ Announces Acquisition Of The CGM Assets Of Waveform Technologies, Inc.; Upfront Payment Of $12.5M Cash And 9M ADSs
1
$Trinity Biotech(TRIB.US$ Trinity Biotech (NASDAQ:TRIB) shares rose 25.13% to $0.54. The company's market cap stands at $20.7 million.
$Trinity Biotech(TRIB.US$ Trinity Biotech Announces Acquisition Of The CGM Assets Of Waveform Technologies, Inc.; Upfront Payment Of $12.5M Cash And 9M ADSs
1
News
$Trinity Biotech(TRIB.US$ Trinity Biotech partners with Bayer to launch CGM device in China and India
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg